Strategies to enhance tilapia immunity to improve their health in aquaculture

被引:69
作者
Wang, Bei [1 ]
Thompson, Kim D. [2 ]
Wangkahart, Eakapol [3 ]
Yamkasem, Jidapa [4 ]
Bondad-Reantaso, Melba G. [5 ]
Tattiyapong, Puntanat [4 ]
Jian, Jianchang [1 ]
Surachetpong, Win [4 ]
机构
[1] Guangdong Ocean Univ, Coll Fisheries, Guangdong Prov Key Lab Aquat Anim Dis Control & H, Zhanjiang City, Guangdong, Peoples R China
[2] Moredun Res Inst, Aquaculture Res Grp, Edinburgh, Midlothian, Scotland
[3] Mahasarakham Univ, Fac Technol, Appl Anim & Aquat Sci Res Unit, Lab Fish Immunol & Nutrigen, Maha Sarakham, Thailand
[4] Kasetsart Univ, Fac Vet Med, Bangkok 10900, Thailand
[5] Food & Agr Org United Nations, Fisheries & Aquaculture Div, Rome, Italy
关键词
emerging pathogen; immune response; immunostimulation; vaccine; OREOCHROMIS-NILOTICUS L; LAKE VIRUS TILV; STREPTOCOCCUS-AGALACTIAE INFECTION; RED HYBRID TILAPIA; NILE-TILAPIA; GUT MICROBIOTA; AEROMONAS-HYDROPHILA; GROWTH-PERFORMANCE; SACCHAROMYCES-CEREVISIAE; BACILLUS-SUBTILIS;
D O I
10.1111/raq.12731
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
Various emerging and re-emerging diseases, such as streptococcosis, tilapia lake virus disease and infectious spleen and kidney necrosis virus disease, have had a significant economic impact on the tilapia industry over the last decade. These diseases have resulted in high levels of morbidity and mortality, production losses and trade restrictions. In the absence of effective husbandry management, disease prevention strategies and appropriate biosecurity measures, infectious diseases will continue to challenge the sustainability of global tilapia aquaculture. Strategies used to reduce the impact of disease include feeding probiotic and prebiotic supplements to enhance tilapia health and to modulate the fish's gut microbiota to improve gut health. Herbal medicines and immunostimulants are also used to enhance immunity to disease, while vaccines are available, or are under development, for a number of economically important pathogens affecting tilapia culture. This review provides an overview of the benefits of enhancing the immune response of tilapia to improve their health, and in turn reduce the levels of pathogens within tilapia farming systems.
引用
收藏
页码:41 / 56
页数:16
相关论文
共 206 条
[81]   Tilapia lake virus: a threat to the global tilapia industry? [J].
Jansen, Mona Dverdal ;
Ha Thanh Dong ;
Mohan, Chadag Vishnumurthy .
REVIEWS IN AQUACULTURE, 2019, 11 (03) :725-739
[82]   Genomic selection for resistance to Francisellosis in commercial Nile tilapia population: Genetic and genomic parameters, correlation with growth rate and predictive ability [J].
Joshi, Rajesh ;
Almeida, Diones Bender ;
Costa, Arthur Roberto da ;
Skaarud, Anders ;
Pereira, Ulisses de Padua ;
Knutsen, Tim M. ;
Moen, Thomas ;
Alvarez, Alejandro Tola .
AQUACULTURE, 2021, 537
[83]   Immersion Vaccination by a Biomimetic-Mucoadhesive Nanovaccine Induces Humoral Immune Response of Red Tilapia (Oreochromis sp.) against Flavobacterium columnare Challenge [J].
Kitiyodom, Sirikorn ;
Yata, Teerapong ;
Thompson, Kim D. ;
Costa, Janina ;
Elumalai, Preetham ;
Katagiri, Takayuki ;
Temisak, Sasithon ;
Namdee, Katawut ;
Rodkhum, Channarong ;
Pirarat, Nopadon .
VACCINES, 2021, 9 (11)
[84]   Modulation of the mucosal immune response of red tilapia (Oreochromis sp.) against columnaris disease using a biomimetic-mucoadhesive nanovaccine [J].
Kitiyodom, Sirikorn ;
Trullas, Clara ;
Rodkhum, Channarong ;
Thompson, Kim D. ;
Katagiri, Takayuki ;
Temisak, Sasithon ;
Namdee, Katawut ;
Yata, Teerapong ;
Pirarat, Nopadon .
FISH & SHELLFISH IMMUNOLOGY, 2021, 112 :81-91
[85]  
Kocher A., 2004, Interfacing immunity, gut health and performance, P107
[86]   The contribution of medicinal plants to tilapia aquaculture: a review [J].
Kuebutornye, Felix K. A. ;
Abarike, Emmanuel Delwin .
AQUACULTURE INTERNATIONAL, 2020, 28 (03) :965-983
[87]   A review on the application of Bacillus as probiotics in aquaculture [J].
Kuebutornye, Felix K. A. ;
Abarike, Emmanuel Delwin ;
Lu, Yishan .
FISH & SHELLFISH IMMUNOLOGY, 2019, 87 :820-828
[88]   Two serological types of group B hemolytic streptococci with related, but not identical, type-specific substances [J].
Lancefield, RC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1938, 67 (01) :25-40
[89]   Characterization of the gut microbiota of three commercially valuable warmwater fish species [J].
Larsen, A. M. ;
Mohammed, H. H. ;
Arias, C. R. .
JOURNAL OF APPLIED MICROBIOLOGY, 2014, 116 (06) :1396-1404
[90]  
Hai LD, 2020, THAI J VET MED, V50, P103